Company Overview
NOVABAY PHARMACEUTICALS, INC.
SDEVRevenue vs. Cost of Revenue
Revenue
Cost of Revenue
Total Operating Expenses vs. Operating Income
Total Operating Expenses
Operating Income
Net Income
Net Income
Revenue
—M
2025 FY
Net Income
-22M
2025 FY
Shares Outstanding
6M
2025 FY
EPS
-3.8USD
2025 FY
Company Information
SIC Code
2834
CIK Code
1389545
Exchange
NYSE
Location
US